Alger Associates, Inc. 13D/13G Filings for Puma Biotechnology, Inc. (PBYI)

Alger Associates, Inc. 13D and 13G filings for Puma Biotechnology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-11-10
4:08 pm
Sale		 2021-10-31 13G Puma Biotechnology, Inc.
PBYI		 Alger Associates, Inc. 890,396
2.180%		 -2,525,607decrease
(-73.93%)		 Filing
2021-02-16
4:51 pm
Purchase		 2020-12-31 13G Puma Biotechnology, Inc.
PBYI		 Alger Associates, Inc. 3,416,003
8.590%		 3,416,003increase
(New Position)		 Filing